167 related articles for article (PubMed ID: 8986008)
1. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics.
Tarazi FI; Florijn WJ; Creese I
Psychopharmacology (Berl); 1996 Dec; 128(4):371-9. PubMed ID: 8986008
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Tarazi FI; Florijn WJ; Creese I
Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats.
See RE; Toga AW; Ellison G
J Neural Transm Gen Sect; 1990; 82(2):93-109. PubMed ID: 1977417
[TBL] [Abstract][Full Text] [Related]
5. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
See RE; Lynch AM; Sorg BA
Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.
Tarazi FI; Moran-Gates T; Gardner MP; Graulich A; Lamy C; Liégeois JF
J Mol Neurosci; 2007; 32(3):192-8. PubMed ID: 17873364
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
Huang N; Ase AR; Hébert C; van Gelder NM; Reader TA
Neurochem Int; 1997 Mar; 30(3):277-90. PubMed ID: 9041559
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic haloperidol and clozapine treatment on AMPA and kainate receptor binding in rat brain.
Schmitt A; May B; Müller B; Jatzko A; Petroianu G; Braus DF; Henn FA
Pharmacopsychiatry; 2003 Nov; 36(6):292-6. PubMed ID: 14663653
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Robertson GS; Fibiger HC
Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.
Lee H; Tarazi FI; Chakos M; Wu H; Redmond M; Alvir JM; Kinon BJ; Bilder R; Creese I; Lieberman JA
Life Sci; 1999; 64(18):1595-602. PubMed ID: 10328519
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs.
Fitzgerald LW; Deutch AY; Gasic G; Heinemann SF; Nestler EJ
J Neurosci; 1995 Mar; 15(3 Pt 2):2453-61. PubMed ID: 7891180
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain.
McCoy L; Cox C; Richfield EK
Eur J Pharmacol; 1996 Dec; 318(1):41-5. PubMed ID: 9007511
[TBL] [Abstract][Full Text] [Related]
14. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
Andersen PH
Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats.
Spurney CF; Baca SM; Murray AM; Jaskiw GE; Kleinman JE; Hyde TM
Synapse; 1999 Dec; 34(4):266-76. PubMed ID: 10529721
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat.
Marcus MM; Nomikos GG; Malmerfelt A; Zachrisson O; Lindefors N; Svensson TH
Brain Res Mol Brain Res; 1997 May; 45(2):275-82. PubMed ID: 9149102
[TBL] [Abstract][Full Text] [Related]
19. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
Wang RY; Liang X
Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
Yu J; Källström L; Wiesel FA; Johnson AE
Synapse; 1999 Dec; 34(3):192-207. PubMed ID: 10523757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
